Published: 8 October 2024
Author(s): Carlos Bertolin-Boronat, Víctor Marcos-Garcés, Hector Merenciano-González, Nerea Perez, Candelas Pérez del Villar, Jose Gavara, Maria P. Lopez-Lereu, Jose V. Monmeneu, Cristian Herrera Flores, Blanca Domenech-Ximenos, Francisco Jesús López-Fornás, Cesar Rios-Navarro, Elena de Dios, David Moratal, Jose T. Ortiz-Pérez, Antoni Bayes-Genis, Jose F Rodríguez-Palomares, Julio Nuñez, Pedro L. Sánchez, Juan Sanchis, Vicente Bodi
Section: Original Article
Left ventricular thrombus (LVTh) is a rare but serious complication following ST-segment elevation myocardial infarction (STEMI) [1–4]. During the prethrombolytic era, LVTh was detected in up to 60% of patients [5,6]. However, the risk of developing this complication has decreased progressively in parallel with the implementation of emerging reperfusion strategies in STEMI [7].
